In human, mutations in EIF2AK4, encoding GCN2, cause a loss of function associated with pulmonary veno‐occlusive disease (PVOD), a rare form of pulmonary arterial hypertension (Montani et al, 2016). Here, EIF2AK4 is linked to pulmonary venoocclusive disease.